The success of Sildenafil initially sparked a period of growth for major pharmaceutical companies, however recent changes present a complicated scenario for investors. Generic alternatives are reducing revenue, and https://amaantwsi547838.blogsmine.com/41501440/viagra-and-pharma-a-risky-investment